Laudenbach, M., Baruffaldi, F., Vervacke, J. S., Distefano, M. D., Titcombe, P. J., Mueller, D. L., . . . Pravetoni, M. (2015). The frequency of naïve and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse. J Immunol.

Laudenbach, Megan, Federico Baruffaldi, Jeffrey S. Vervacke, Mark D. Distefano, Philip J. Titcombe, Daniel L. Mueller, Noah J. Tubo, Thomas S. Griffith, and Marco Pravetoni. "The Frequency of Naïve and Early-activated Hapten-specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse." J Immunol 2015.

Laudenbach, Megan, et al. "The Frequency of Naïve and Early-activated Hapten-specific B Cell Subsets Dictates the Efficacy of a Therapeutic Vaccine against Prescription Opioid Abuse." J Immunol 2015.